These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26084585)

  • 1. Vascular adhesion protein 1 in nonalcoholic steatohepatitis: a novel biomarker?
    Torok NJ
    Hepatology; 2015 Oct; 62(4):1313-5. PubMed ID: 26084585
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis.
    Weston CJ; Shepherd EL; Claridge LC; Rantakari P; Curbishley SM; Tomlinson JW; Hubscher SG; Reynolds GM; Aalto K; Anstee QM; Jalkanen S; Salmi M; Smith DJ; Day CP; Adams DH
    J Clin Invest; 2015 Feb; 125(2):501-20. PubMed ID: 25562318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human vascular adhesion proteın-1 (VAP-1): serum levels for hepatocellular carcinoma in non-alcoholic and alcoholic fatty liver disease.
    Kemik O; Sümer A; Kemik AS; Itik V; Dulger AC; Purisa S; Tuzun S
    World J Surg Oncol; 2010 Sep; 8():83. PubMed ID: 20849600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating periostin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Papatheodorou A; Kokkoris P; Terpos E
    Endocrine; 2017 May; 56(2):438-441. PubMed ID: 27738886
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases.
    Kurkijärvi R; Adams DH; Leino R; Möttönen T; Jalkanen S; Salmi M
    J Immunol; 1998 Aug; 161(3):1549-57. PubMed ID: 9686623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular adhesion protein-1: Role in human pathology and application as a biomarker.
    Pannecoeck R; Serruys D; Benmeridja L; Delanghe JR; van Geel N; Speeckaert R; Speeckaert MM
    Crit Rev Clin Lab Sci; 2015; 52(6):284-300. PubMed ID: 26287391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease.
    Kurkijärvi R; Yegutkin GG; Gunson BK; Jalkanen S; Salmi M; Adams DH
    Gastroenterology; 2000 Oct; 119(4):1096-103. PubMed ID: 11040196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte trafficking mediated by vascular adhesion protein-1: implications for immune targeting and cardiovascular disease.
    Alexander JS; Granger DN
    Circ Res; 2000 Jun; 86(12):1190-2. PubMed ID: 10864906
    [No Abstract]   [Full Text] [Related]  

  • 9. Enzymatic control of leukocyte trafficking: role of VAP-1.
    Salmi M; Jalkane S
    Adv Exp Med Biol; 2002; 512():57-63. PubMed ID: 12405188
    [No Abstract]   [Full Text] [Related]  

  • 10. Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke?
    Ziliotto N; Zivadinov R; Jakimovski D; Bergsland N; Ramasamy DP; Weinstock-Guttman B; Ramanathan M; Marchetti G; Bernardi F
    Thromb Haemost; 2019 Jan; 119(1):175-178. PubMed ID: 30597511
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic consequences of vascular adhesion protein-1 expression.
    Weston CJ; Adams DH
    J Neural Transm (Vienna); 2011 Jul; 118(7):1055-64. PubMed ID: 21512782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating vascular adhesion protein-1(VAP-1): a possible biomarker for liver fibrosis associated with chronic hepatitis B and C.
    Öksüz Z; Üçbilek E; Serin MS; Yaraş S; Temel GO; Sezgin O
    Braz J Microbiol; 2020 Dec; 51(4):1757-1763. PubMed ID: 32959205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative modification of leukocyte adhesion.
    Ley K; Deem TL
    Immunity; 2005 Jan; 22(1):5-7. PubMed ID: 15664154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case-control study.
    Zhu JZ; Zhu HT; Dai YN; Li CX; Fang ZY; Zhao DJ; Wan XY; Wang YM; Wang F; Yu CH; Li YM
    Endocrine; 2016 Jan; 51(1):91-100. PubMed ID: 26362060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model.
    Nakatsu Y; Seno Y; Kushiyama A; Sakoda H; Fujishiro M; Katasako A; Mori K; Matsunaga Y; Fukushima T; Kanaoka R; Yamamotoya T; Kamata H; Asano T
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G42-51. PubMed ID: 25999428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular amine oxidases are needed for leukocyte extravasation into inflamed joints in vivo.
    Marttila-Ichihara F; Smith DJ; Stolen C; Yegutkin GG; Elima K; Mercier N; Kiviranta R; Pihlavisto M; Alaranta S; Pentikäinen U; Pentikäinen O; Fülöp F; Jalkanen S; Salmi M
    Arthritis Rheum; 2006 Sep; 54(9):2852-62. PubMed ID: 16947396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis.
    Kamada Y; Fujii H; Fujii H; Sawai Y; Doi Y; Uozumi N; Mizutani K; Akita M; Sato M; Kida S; Kinoshita N; Maruyama N; Yakushijin T; Miyazaki M; Ezaki H; Hiramatsu N; Yoshida Y; Kiso S; Imai Y; Kawada N; Takehara T; Miyoshi E
    Proteomics Clin Appl; 2013 Oct; 7(9-10):648-56. PubMed ID: 23775887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1/semicarbazide-sensitive amine oxidase (sVAP-1) and cardiometabolic risk markers in apparently healthy adolescents: a cross-sectional study.
    Gurecká R; Koborová I; Csongová M; Šebek J; Šebeková K
    Glycoconj J; 2016 Aug; 33(4):599-606. PubMed ID: 27300745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-based novel biomarkers for nonalcoholic steatohepatitis.
    Qiu Y; Wang S; Wan T; Ye M; Jiang R; Pei L; Yang L
    Biomark Med; 2018 May; 12(5):501-515. PubMed ID: 29712439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.